For people with type 1 or type 2 diabetes and the companies developing technologies to help them, the International Conference on Advanced Technologies & Treatments for Diabetes delivered an abundance ...
Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...
Research suggests that automated insulin delivery (AID) systems may play a significant role in enhancing glucose management.
Amsterdam played host to this year's edition of the International Conference on Advanced Technologies & Treatments for ...
Insulet Corporation (NASDAQ:PODD) showcases a high Return on Invested Capital (ROIC) of 16.28% and a Weighted Average Cost of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results